Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Nov-23 10:00 PM View:  | Maravic Magovcevic Ivana President and CEO Director | Vigil Neuroscience, Inc. (VIGL) | 20-Nov-23 | Purchase | 4,000 | $3.75 | $15,000.00 | 2% 203.69K to 207.69K | |
| 22-Nov-22 9:45 PM View: | Papapetropoulos Spyridon Chief Medical Officer | Vigil Neuroscience, Inc. (VIGL) | 18-Nov-22 | Option Exercise | 300 | $1.89 | $567.00 | 8% 4.0K to 4.3K | |
| 22-Nov-22 9:45 PM View: | Papapetropoulos Spyridon Chief Medical Officer | Vigil Neuroscience, Inc. (VIGL) | 18-Nov-22 | Planned Option Sale | 300 | $14.00 | $4,200.00 | (7%) 4.3K to 4.0K | |
| 17-May-22 9:06 PM View: | Thorp Clay Director | Vigil Neuroscience, Inc. (VIGL) | 17-May-22 | Purchase | 14,893 | $2.97 | $44,189.00 | < 1% 1.54M to 1.56M | |
| 17-May-22 9:06 PM View: | Thorp Clay Director | Vigil Neuroscience, Inc. (VIGL) | 16-May-22 | Purchase | 21,802 | $2.76 | $60,221.50 | 1% 1.52M to 1.54M | |
| 06-May-22 7:00 AM View: | Thackaberry Evan SVP, Head of Early Development | Vigil Neuroscience, Inc. (VIGL) | 05-May-22 | Purchase | 1,500 | $4.00 | $6,000.00 | 100% 0 to 1.5K | |
| 04-May-22 7:00 AM View: | Papapetropoulos Spyridon Chief Medical Officer | Vigil Neuroscience, Inc. (VIGL) | 03-May-22 | Purchase | 4,000 | $3.40 | $13,591.20 | 100% 0 to 4.0K | |
| 04-May-22 7:00 AM View: | Verni Christopher General Counsel | Vigil Neuroscience, Inc. (VIGL) | 03-May-22 | Purchase | 4,000 | $3.77 | $15,074.40 | 100% 0 to 4.0K | |
| 04-May-22 7:00 AM View: | Ziolkowski Jennifer Lynn Chief Financial Officer | Vigil Neuroscience, Inc. (VIGL) | 03-May-22 | Purchase | 4,000 | $3.77 | $15,097.60 | 100% 0 to 4.0K | |
| 04-May-22 7:00 AM View: | Maravic Magovcevic Ivana President and CEO Director | Vigil Neuroscience, Inc. (VIGL) | 03-May-22 | Purchase | 1,000 | $3.94 | $3,940.20 | < 1% 202.69K to 203.69K | |
| 04-May-22 7:00 AM View: | Maravic Magovcevic Ivana President and CEO Director | Vigil Neuroscience, Inc. (VIGL) | 02-May-22 | Purchase | 4,000 | $3.61 | $14,438.80 | 2% 198.69K to 202.69K | |
| 28-Mar-22 4:44 PM View: | Thorp Clay Director | Vigil Neuroscience, Inc. (VIGL) | 28-Mar-22 | Purchase | 3,000 | $7.20 | $21,604.20 | < 1% 1.52M to 1.52M | |
| 11-Jan-22 9:15 PM View: | Atlas Venture Fund Xii, L.P. 10% Owner | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Purchase Duplicate | 535,000 | $14.00 | $7,490,000.00 | 10% 5.3M to 5.84M | |
| 11-Jan-22 9:20 PM View: | Thorp Clay Director | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Conversion | 1,254,340 | -- | -- | 100% 0 to 1.25M | |
| 13-Jan-22 4:06 PM View: | Cormorant Asset Management,... | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Conversion | 616,786 | -- | -- | 100% 0 to 616.79K | |
| 11-Jan-22 5:53 PM View: | Alexandria Venture Investme... 10% Owner | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Conversion | 192,973 | -- | -- | 100% 0 to 192.97K | |
| 11-Jan-22 9:11 PM View: | Vitorovic Stefan Director | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Conversion | 3,340,930 | -- | -- | 100% 0 to 3.34M | |
| 11-Jan-22 9:11 PM View: | Booth Bruce Director | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Purchase | 535,000 | $14.00 | $7,490,000.00 | 10% 5.3M to 5.84M | |
| 11-Jan-22 9:18 PM View: | Vida Ventures Gp Iii, L.L.C. 10% Owner | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Conversion Duplicate | 3,340,930 | -- | -- | 100% 0 to 3.34M | |
| 11-Jan-22 9:20 PM View: | Thorp Clay Director | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Purchase | 265,000 | $14.00 | $3,710,000.00 | 21% 1.25M to 1.52M | |
| 11-Jan-22 8:18 PM View: | Northpond Ventures Gp, LLC 10% Owner | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Conversion | 3,859,500 | -- | -- | 100% 0 to 3.86M | |
| 11-Jan-22 9:11 PM View: | Vitorovic Stefan Director | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Purchase | 1,675,000 | $14.00 | $23,450,000.00 | 50% 3.34M to 5.02M | |
| 11-Jan-22 9:15 PM View: | Atlas Venture Fund Xii, L.P. 10% Owner | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Conversion Duplicate | 3,859,500 | -- | -- | 268% 1.44M to 5.3M | |
| 11-Jan-22 9:18 PM View: | Vida Ventures Gp Iii, L.L.C. 10% Owner | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Purchase Duplicate | 1,675,000 | $14.00 | $23,450,000.00 | 50% 3.34M to 5.02M | |
| 11-Jan-22 9:33 PM View: | Amgen Inc 10% Owner | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Conversion | 3,206,280 | -- | -- | 100% 0 to 3.21M | |
| 11-Jan-22 8:18 PM View: | Northpond Ventures Gp, LLC 10% Owner | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Purchase | 355,000 | $14.00 | $4,970,000.00 | 9% 3.86M to 4.21M | |
| 11-Jan-22 9:11 PM View: | Booth Bruce Director | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Conversion Duplicate | 3,859,500 | -- | -- | 268% 1.44M to 5.3M |
